Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly Preps Rejected Rheumatoid Arthritis Drug for Resubmission
Eli Lilly Preps Rejected Rheumatoid Arthritis Drug for Resubmission
Eli Lilly Preps Rejected Rheumatoid Arthritis Drug for Resubmission
Submitted by
admin
on August 30, 2017 - 11:12am
Source:
Xconomy
News Tags:
Eli Lilly
rheumatoid arthritis
FDA
baricitinib
Headline:
Eli Lilly Preps Rejected Rheumatoid Arthritis Drug for Resubmission
Do Not Allow Advertisers to Use My Personal information
